Bufalin inhibits endothelial cell proliferation and angiogenesis in vitro
- 1 November 1996
- journal article
- Published by Elsevier in Life Sciences
- Vol. 60 (2) , 127-134
- https://doi.org/10.1016/s0024-3205(96)00602-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Selective Inhibitory Effect of Bufalin on Growth of Human Tumor Cells in vitro: Association with the Induction of Apoptosis in Leukemia HL‐60 CellsJapanese Journal of Cancer Research, 1994
- Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitorBiochemical and Biophysical Research Communications, 1991
- Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane.The Journal of cell biology, 1990
- Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related PeptidesScience, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.Journal of Clinical Investigation, 1989
- Angiogenic FactorsScience, 1987
- Inhibition of endothelial cell proliferation by type β-transforming growth factor: Interactions with acidic and basic fibroblast growth factorsBiochemical and Biophysical Research Communications, 1986
- Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis)Journal of Cellular Physiology, 1986
- Protamine is an inhibitor of angiogenesisNature, 1982